Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2026-01-01 @ 3:26 PM
Study NCT ID:
NCT00216203
Status:
COMPLETED
Last Update Posted:
2016-09-29
First Post:
2005-09-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer
Sponsor:
Nasser Hanna, M.D.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HOG LUN04-79
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None